Blog | HemaCare

Research on Universal Cancer Vaccine

Sep 17, 2018 10:13:00 AM / by Stacy Matthews Branch, DVM, PhD posted in Cancer, cancer immunotherapy, cancer treatment, Immunotherapy, T Cells, vaccines

0 Comments

Researchers are hoping to develop a cancer vaccine to improve a patient’s immune system so they can destroy the cancer cells.

The objective of therapeutic cancer vaccines is to support and enhance a patient’s immune system to recognize and destroy cancer cells while sparing surrounding normal cells. The first therapeutic immune cell–based cancer vaccine approved by the U.S. Food and Drug Administration is Sipuleucel-T. Administration of this vaccine in patients with hormone-refractory prostate cancer lead to an increase in overall survival. Boosting T-cell responses against antigens that cause a number of diseases has been approached by autologous transfer of dendritic cells. A pilot study was conducted using dendritic cells pulsed with tumor lysate from patients with ovarian cancer. Vaccination of the patients stimulated T-cell responses to the tumor antigen led to an increase in patient survival. 

Read More

Brain Cancer Vaccine Could Improve Prognosis

Jul 30, 2018 10:18:00 AM / by Stacy Matthews Branch, DVM, PhD posted in Dendritic Cells, vaccines

0 Comments

Immunotherapy for glioblastoma has been considered an option for patients and extend life of patients.

Glioblastoma multiforme is an aggressive cancer of the brain or spinal cord that originates from astrocytes. Although this type of cancer is not age specific, it is diagnosed more often in older patients. Glioblastoma is very difficult to treat, and current options include surgery, chemotherapy, radiotherapy, use of electrical fields (tumor treating fields), and targeted therapies to prevent tumor blood vessel formation. On average, people live for about 15 months after diagnosis despite receiving the standard treatments for glioblastoma.

Read More

HIV Research Marches on With Exciting Leads

Mar 11, 2015 1:00:54 PM / by James Sanchez posted in CCR5, CD4, research, vaccines

0 Comments

HemaCare reports 3 recent findings generating enthusiasm in the HIV research community

Read More

Emerging Trends in Therapy from BIO2014

Jul 7, 2014 12:55:22 PM / by Maria posted in prescription, Innovation, microbiome, vaccines

0 Comments

BIO2014, true to the expectations by the biotech industry, provided that unique confluence where the three different streams of research, business and therapy could meet, discuss and arrive at a consensus. HemaCare was keen to be abreast of the latest developments and here we highlight some of the emerging trends in therapy.

Read More

Subscribe Here!

Posts by Topic

see all

Recent Posts